Penumbra - 10 Year Stock Price History | PEN
Historical daily share price chart and data for Penumbra since 2015 adjusted for splits and dividends. The latest closing stock price for Penumbra as of June 10, 2025 is 255.73.
- The all-time high Penumbra stock closing price was 344.06 on June 30, 2023.
- The Penumbra 52-week high stock price is 310.00, which is 21.2% above the current share price.
- The Penumbra 52-week low stock price is 148.00, which is 42.1% below the current share price.
- The average Penumbra stock price for the last 52 weeks is 235.47.
| Penumbra Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 273.2276 | 239.9900 | 303.7600 | 237.2800 | 255.7300 | 7.68% |
| 2024 | 215.4874 | 244.7700 | 273.1500 | 163.6400 | 237.4800 | -5.59% |
| 2023 | 265.1316 | 221.2000 | 344.0600 | 181.4400 | 251.5400 | 13.07% |
| 2022 | 184.0640 | 283.9800 | 283.9800 | 116.0900 | 222.4600 | -22.57% |
| 2021 | 266.1209 | 175.6000 | 310.7000 | 175.6000 | 287.3200 | 64.18% |
| 2020 | 193.1285 | 163.7900 | 272.8300 | 124.3400 | 175.0000 | 6.53% |
| 2019 | 150.3881 | 123.0700 | 183.4000 | 115.8400 | 164.2700 | 34.43% |
| 2018 | 130.1708 | 90.3500 | 165.9500 | 84.6000 | 122.2000 | 29.86% |
| 2017 | 86.5337 | 64.0500 | 115.8500 | 64.0500 | 94.1000 | 47.49% |
| 2016 | 59.2329 | 55.7100 | 79.3900 | 42.0000 | 63.8000 | 18.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.933B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.582B | 82.60 |
| Thermo Fisher Scientific (TMO) | United States | $154.218B | 18.65 |
| Edwards Lifesciences (EW) | United States | $44.793B | 29.37 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $41.707B | 47.93 |
| DexCom (DXCM) | United States | $33.596B | 51.93 |
| IQVIA Holdings (IQV) | United States | $26.668B | 14.94 |
| Mettler-Toledo (MTD) | United States | $24.844B | 29.55 |
| STERIS (STE) | Ireland | $23.875B | 26.30 |
| Waters (WAT) | United States | $20.729B | 29.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $14.389B | 15.63 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Masimo (MASI) | United States | $9.319B | 34.38 |
| Globus Medical (GMED) | United States | $8.169B | 19.47 |
| Teleflex (TFX) | United States | $5.447B | 8.99 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| TransMedics (TMDX) | United States | $4.715B | 102.50 |
| Integer Holdings (ITGR) | United States | $4.259B | 22.31 |
| PROCEPT BioRobotics (PRCT) | United States | $3.478B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.525B | 15.03 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Veracyte (VCYT) | United States | $2.181B | 30.60 |
| Elekta AB (EKTAY) | Sweden | $2.013B | 18.10 |
| Alphatec Holdings (ATEC) | United States | $1.742B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.76 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.079B | 5.74 |
| Beta Bionics (BBNX) | United States | $0.842B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.23 |
| RxSight (RXST) | United States | $0.622B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.561B | 13.15 |
| Delcath Systems (DCTH) | United States | $0.555B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| AxoGen (AXGN) | United States | $0.474B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.379B | 10.09 |
| ClearPoint Neuro (CLPT) | United States | $0.373B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.371B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Accuray (ARAY) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.118B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 50.00 |
| EnVVeno Medical (NVNO) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.36 |